Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$223.92 - $287.77 $16,570 - $21,294
-74 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$282.99 - $369.05 $27.4 Million - $35.8 Million
-96,932 Reduced 99.92%
74 $21,000
Q2 2021

Jul 19, 2021

SELL
$259.0 - $414.71 $5.09 Million - $8.15 Million
-19,664 Reduced 16.85%
97,006 $33.6 Million
Q1 2021

Apr 16, 2021

BUY
$242.95 - $284.63 $6.22 Million - $7.29 Million
25,605 Added 28.12%
116,670 $32.6 Million
Q4 2020

Feb 03, 2021

SELL
$236.26 - $355.63 $957,561 - $1.44 Million
-4,053 Reduced 4.26%
91,065 $22.3 Million
Q3 2020

Oct 15, 2020

SELL
$264.77 - $305.71 $703,493 - $812,271
-2,657 Reduced 2.72%
95,118 $27 Million
Q2 2020

Jul 27, 2020

BUY
$258.66 - $342.55 $680,793 - $901,591
2,632 Added 2.77%
97,775 $26.2 Million
Q1 2020

Apr 17, 2020

BUY
$268.85 - $341.04 $2.28 Million - $2.89 Million
8,469 Added 9.77%
95,143 $30.1 Million
Q4 2019

Jan 08, 2020

SELL
$220.06 - $304.07 $3.54 Million - $4.89 Million
-16,094 Reduced 15.66%
86,674 $25.7 Million
Q3 2019

Oct 10, 2019

SELL
$217.44 - $243.88 $1.38 Million - $1.54 Million
-6,335 Reduced 5.81%
102,768 $23.9 Million
Q2 2019

Jul 11, 2019

BUY
$219.29 - $241.72 $84,207 - $92,820
384 Added 0.35%
109,103 $25.5 Million
Q1 2019

Apr 17, 2019

SELL
$216.71 - $338.96 $866,623 - $1.36 Million
-3,999 Reduced 3.55%
108,719 $25.7 Million
Q4 2018

Feb 04, 2019

BUY
$278.5 - $352.75 $1.56 Million - $1.97 Million
5,586 Added 5.21%
112,718 $33.9 Million
Q3 2018

Nov 09, 2018

SELL
$293.51 - $383.83 $3.77 Million - $4.92 Million
-12,828 Reduced 10.69%
107,132 $37.9 Million
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $5.66 Million - $6.74 Million
21,971 Added 22.42%
119,960 $34.8 Million
Q1 2018

May 08, 2018

SELL
$260.13 - $367.91 $2.76 Million - $3.9 Million
-10,599 Reduced 9.76%
97,989 $26.8 Million
Q4 2017

Jan 11, 2018

BUY
$307.64 - $344.58 $916,151 - $1.03 Million
2,978 Added 2.82%
108,588 $34.6 Million
Q3 2017

Oct 31, 2017

BUY
$281.15 - $329.69 $29.7 Million - $34.8 Million
105,610
105,610 $33.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.